Drug intelligence / Profile preview

nicotinamide 8-bromo-adenine dinucleotide phosphate

Development stage
Unknown
Modality
Small Molecules
01

Overview

Nicotinamide 8-bromo‐adenine dinucleotide phosphate (NA8BrADP) is a synthetic analog of nicotinamide adenine dinucleotide phosphate (NADP+), which is an essential cofactor in many enzymatic redox reactions. The compound features a brominated adenine moiety at the eighth position. As an NADP+ analog and member of the (5'→5')‐dinucleotides class of organic compounds, it may be used experimentally to probe or modulate NADP+-dependent biochemical pathways or enzyme activities. There are no approved therapeutic indications for this molecule; it is classified as experimental and primarily used in research settings[1][2][3].

Other names
Nicotinamide 8-bromo-adenine dinucleotide phosphateNicotinamide8-bromo-adenine dinucleotide phosphateNicotinamide-8-bromo-adenine dinucleotide phosphate[(2R,3R,4R,5R)-5-(6-amino-8-bromopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl][(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan -2 -yl]methyl phosphate(((2R,3R,4R,5R)-5-(6-amino–8-bromopurin–9–yl)–3–hydroxy–4-phosphonooxyoxolan–2–yl)methoxy-hydroxyphosphoryl)((2 R , 3 S , 4 R , 5 R ) – 5 – ( 3 – carbamoylpyridin –1 –ium –1 – yl ) – 3 , 4-dihydroxyoxolan -2 - yl ) methyl phosphate

Beyond the preview

Go deeper on nicotinamide 8-bromo-adenine dinucleotide phosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nicotinamide 8-bromo-adenine dinucleotide phosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call